openPR Logo
Press release

Cardiomyopathy Market Segmentation, Forecast, Analysis, Industry Size and Share to 2025

03-17-2020 02:32 PM CET | Health & Medicine

Press release from: Orion Market Research

Cardiomyopathy is a disease of the heart muscle. It affects any age group and is a serious lifelong condition. The major factors that contributes in the growth of the market are advancement in understanding and managing cardiomyopathy and rise in incidences of congestive heart failure, coronary heart disease, and heart attack. Further, increasing trend of minimally invasive technology and availability of remote monitoring solutions are estimated to contribute in the growth of the market. However, high cost of diagnosis & treatment and lack of public awareness are considered to be the major restraining factors in the growth of the market. Increasing medical tourism in emerging countries and increasing research and development for the cardiomyopathy treatment are developing numerous opportunities for the growth of the cardiomyopathy market.

Request a Free Sample of our Report on Cardiomyopathy Market: https://www.omrglobal.com/request-sample/cardiomyopathy-market

The major types of cardiomyopathy include dilated cardiomyopathy, hypertrophic cardiomyopathy and restrictive cardiomyopathy. These types of cardiomyopathy can be inherited. Further, it can be caused by viral infection in heart or heart attack. Dilated cardiomyopathy occurs when the muscles of heart begin to stretch and become thinner. Hypertrophic cardiomyopathy happens when the muscles of heart cells enlarge and cause the walls of the heart to thicken. Restrictive cardiomyopathy tends to affect older adults. The heart becomes rigid as the abnormal tissue replaces the normal heart muscle so the heart muscle is unable to relax.

A Full Report of Cardiomyopathy Market is Available at https://www.omrglobal.com/industry-reports/cardiomyopathy-market

Global Cardiomyopathy Market Segmentation

By Type
o Dilated Cardiomyopathy
o Hypertrophic Cardiomyopathy
o Restrictive Cardiomyopathy
o Arrhythmogenic Right Ventricular Dysplasia
o Unclassified Cardiomyopathy

By Diagnosis Test
o Chest X-Ray
o Echocardiogram
o Electrocardiogram (Ecg)
o Treadmill Stress Test
o Cardiac Catheterization
o Cardiac Mri
o Cardiac Ct Scan
o Genetic Testing Or Screening

By Treatment
o Medication
o Surgically Implanted Devices
o Nonsurgical Procedures
o Surgery

By End User
o Homecare
o Hospitals And Clinics
o Diagnostic Center
o Other

Company Profiles
o Abbott Diagnostics
o Array Biopharma, Inc.
o Astrazeneca Plc
o Becton And Dickson & Co.
o Bg Medicine Inc.
o Biomerieux
o Bio-Rad Laboratories
o Boston Scientific Corporation
o Bristol-Myers Squibb
o Cisbio Bioassays
o Covance

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/cardiomyopathy-market

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404

About us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiomyopathy Market Segmentation, Forecast, Analysis, Industry Size and Share to 2025 here

News-ID: 1971568 • Views:

More Releases from Orion Market Research

North American Cardiovascular Devices Market to Witness Growth Acceleration by 2031
North American Cardiovascular Devices Market to Witness Growth Acceleration by 2 …
North American cardiovascular devices market is projected to grow at a significant CAGR of 5.6% during the forecast period. The market growth in North America can be attributed to the rising geriatric population, frequent US FDA approvals for innovative cardiovascular devices, and the growing adoption of minimally invasive/non-invasive cardiac surgeries. There are several cardiac health organizations working in the US, such as American Heart Association. The geriatric population is more
Topical Drug Delivery Market Will Exhibit an Impressive Expansion by 2024-2031
Topical Drug Delivery Market Will Exhibit an Impressive Expansion by 2024-2031
The global topical drug delivery market is anticipated to grow at a considerable CAGR of 6.1% during the forecast period. The key factor contributing to the market growth includes the increasing approvals, grants, and clearance by government authorities and regulatory bodies for topical drugs. For instance, • In July 2022, Alembic Pharmaceuticals, (Aleor Dermaceuticals) received the US Food and Drug Administration (US FDA) approval for its Abbreviated New Drug Application (ANDA) for
Surgical Retractors Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Surgical Retractors Market Size, Trends, Latest Insights, Analysis and Forecast …
The global surgical retractors market is anticipated to grow at a considerable CAGR of 6.3% during the forecast period. The increasing research and development activities for the development of new and advanced medical devices by the pharmaceutical and biotechnology companies. Increasing demand for the new surgical devices by the end-users are key factors that are contributing to the growth of the surgical retractors market. For instance, • In June 2022, U.S.
Medical Packaging Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Medical Packaging Market Size, Trends, Latest Insights, Analysis and Forecast 20 …
The global medical packaging market is anticipated to grow with a significant CAGR of 6.1% during the forecast period. The growth of the medical packaging market is attributed to the rapidly changing healthcare industry. The medical packaging market is continuously experiencing various changes owing to the outbreak of new diseases, increasing regulatory norms, and growth in advanced healthcare systems. Furthermore, increasing development in diagnostics, pathological and other allied medical equipment

All 5 Releases


More Releases for Cardiomyopathy

Global Dilated Cardiomyopathy Market Insights, Forecast
Dilated Cardiomyopathy (DCM) refers to the cardiac hypertrophy, cannot effectively pump blood. Dilated Cardiomyopathy (DCM) is due to genetic or other disease caused by a heart disease, it respectively affect the ventricles of the heart and heart, the inferior vena chamber and the upper Chambers of the heart. The global Dilated Cardiomyopathy market is valued at 180 million US$ in 2018 and will reach 290 million US$ by the end
Dilated Cardiomyopathy Market Opportunity Analysis, 2026 – 2026
Dilated cardiomyopathy (DCM) is a condition in which the heart gets enlarged and is not able to efficiently pump blood. The reduced heart function can affect the functioning of other organs such as lungs, liver, and kidney. The heart muscles begin to dilate (stretches), which result in thinning and increased area of the chamber, further it spreads to the right ventricle and atria’s. As the heart chambers dilate, heart muscles
Dilated Cardiomyopathy - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Dilated Cardiomyopathy - Pipeline Review, H1 2017, provides an overview of the Dilated Cardiomyopathy (Cardiovascular) pipeline landscape. Dilated cardiomyopathy (DCM) is a condition in which the heart's ability to pump blood is decreased because the heart's main pumping chamber, the left ventricle, is enlarged and weakened. Symptoms include Fatigue and weakness, Shortness of breath (dyspnea), lightheadedness, dizziness or fainting, persistent cough or wheezing,
Dilated Cardiomyopathy Therapeutics Market Research Report Forecast
A new market research report has been recently published by Transparency market research, a leading market intelligence firm. The research report, titled “Dilated Cardiomyopathy Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020”, presents a market overview, market drivers, opportunities, challenges, product segmentation, and competitive landscape. The research report also features inputs and recommendations from industry experts and professionals to help the
Hypertrophic Cardiomyopathy Therapeutics Market to Gain Significant Impetus from …
The global hypertrophic cardiomyopathy (HCM) therapeutics market is dominated by companies exhibiting high sales. However, generic manufacturers are making their presence felt in the market gradually. As per Transparency Market Research (TMR), the top three companies in the market, Sanofi S.A., Pfizer, Inc., and Merck & Co., accounted for a share of over 64.5%, which points toward a highly consolidated vendor landscape. Browse the Complete Details of this Report at:
Global Hypertrophic Cardiomyopathy Therapeutics Market – Key Trends
The global hypertrophic cardiomyopathy (HCM) therapeutics market is dominated by companies exhibiting high sales. However, generic manufacturers are making their presence felt in the market gradually. As per Transparency Market Research (TMR), the top three companies in the market, Sanofi S.A., Pfizer, Inc., and Merck & Co., accounted for a share of over 64.5%, which points toward a highly consolidated vendor landscape. Intense competition exists among the top companies in